Zusammenfassung
Die Entwicklung von Membranlungen mit niedrigem Flusswiderstand kann das therapeutische Spektrum in der Behandlung des Akuten Lungenversagens (ARDS) erweitern. Für eine Subgruppe von Patienten mit ARDS eröffnet die Einführung der interventionellen Lungenassistenz (ILA) mit Hilfe pumpenloser, durch die arterio-venöse Druckdifferenz betriebener Systeme eine zusätzliche therapeutische Option. Die ILA hat das Potenzial, im Rahmen eines multimodalen Konzeptes frühzeitig in der ARDS-Therapie eingesetzt werden zu können.
Abstract
The development of low resistance oxygenators widens the therapeutic options for patients with acute respiratory failure (ARDS). Pumpless arteriovenous interventional lung assist systems (ILA) can be used in a subgroup of patients with ARDS. ILA might be indicated in earlier stages of ARDS following a multimodal treatment approach.
Schlüsselwörter
ECMO · ILA · ECLA · ARDS · Intensivmedizin
Key words
ECMO · ILA · ECLA · ARDS · intensive care
Literatur
1
Ashbaugh D G, Bigelow D B, Petty T L, Levine B E.
Acute respiratory distress in adults.
Lancet.
1967;
2
319-323
2
Zapol W M, Snider M T, Hill J D, Fallat R J, Bartlett R H, Edmunds L H, Morris A H, Peirce E C 2nd, Thomas A N, Proctor H J, Drinker P A, Pratt P C, Bagniewski A, Miller R G Jr.
Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study.
JAMA.
1979;
242
2193-2196
3
Morris A H, Wallace C J, Menlove R L, Clemmer T P, Orme J F Jr, Weaver L K, Dean N C, Thomas F, East T D, Pace N L.
Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome.
Am J Respir Crit Care Med.
1994;
149
295-305
4
Gattinoni L, Pesenti A, Mascheroni D, Marcolin R, Fumagalli R, Rossi F, Iapichino G, Romagnoli G, Uziel L, Agostoni A.
Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure.
JAMA.
1986;
256
881-886
5
Amato M, Barbas C, Medeiros D, Magaldi R, Schettino G, Lorenzi-Filho G, Kairalla R, Deheinzelin D, Munoz C, Oliveira R, Takagaki T, Carvalho C.
Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome.
N Engl J Med.
1998;
338
347-354
6
Philipp A, Reng C, Behr R, Kaiser M, Birnbaum D.
Extrakorporale Lungenunterstützung ohne Pumpe. Pumpless ECLA - ein Fallbeispiel.
Kardiotechnik.
1997;
I
3-7
7
Brunston R, Tao W, Bidani A, Alpard S, Traber D, Zwischenberger J.
Prolonged hemodynamic stability during arteriovenous carbon dioxide removal for severe respiratory failure.
J Thorac Cardiovasc Surg.
1997;
114
1107-1114
8
Zwischenberger J, Conrad S, Alpard S, Grier L, Bidani A.
Percutaneous extracorporeal arteriovenous CO2 removal for severe respiratory failure.
Ann Thorac Surg.
1999;
68
181-187
9
Tao W, Brunston R, Bidani A, Pirtle P, Dy J, Cardenas V, Traber D, Zwischenberger J.
Significant reduction in minute ventilation and peak inspiratory pressures with arteriovenous CO2 removal during severe respiratory failure.
Crit Care Med.
1997;
25
689-695
10
Reng M, Philipp A, Kaiser M, Pfeifer M, Gruene S, Schoelmerich J.
Pumpless extracorporeal lung assist and adult respiratory distress syndrome.
Lancet.
2000;
356
219-220
11
Brederlau J, Anetseder M, Wagner R, Roesner T, Philipp A, Greim C, Roewer N.
Pumpless extracorporal lung assist in severe blunt chest trauma.
J Cardiothorac Vasc Anesth; in press.
12
Bein T, Kuhr L, Metz C, Woertgen C, Philipp A, Taeger K.
ARDS and severe brain injury. Therapeutic strategies in conflict.
Anaesthesist.
2002;
51
552-556
13
Murphy J, Savage C M, Alpard S, Deyo D, Jayroe J, Zwischenberger J.
Low-dose versus high-dose heparinization during arteriovenous carbon dioxide removal.
Perfusion.
2001;
16
460-468
14
Jayroe J, Alpard S, Wang D, Deyo D, Murphy J, Zwischenberger J.
Hemodynamic stability during arteriovenous carbon dioxide removal for adult respiratory distress syndrome: a prospective randomized outcomes study in adult sheep.
ASAIO J.
2001;
47
211-214
15
Brunston R, Tao W, Bidani A, Alpard S, Traber D, Zwischenberger J.
Prolonged hemodynamic stability during arteriovenous carbon dioxide removal for severe respiratory failure.
J Thorac Cardiovasc Surg.
1997;
114
1107-1114
16
Jayroe J B, Wang D, Deyo D J, Alpard S K, Bidani A, Zwischenberger J.
The effect of augmented hemodynamics on blood flow during arteriovenous carbon dioxide removal.
ASAIO J..
2003;
49
30-34
17
McCulloch P, Forkert P, Froese A.
Lung volume maintenance prevents lung injury during high frequency oscillatory ventilation in surfactant-deficient rabbits.
Am Rev Respir Dis.
1988;
137
1185-1192
18
Derdak S, Mehta S, Stewart T, Smith T, Rogers M, Buchman T, Carlin B, Lowson S, Granton J.
Multicenter Oscillatory Ventilation For Acute Respiratory Distress Syndrome Trial (MOAT) Study Investigators. High-frequency oscillatory ventilation for acute respiratory distress syndrome in adults: a randomized, controlled trial.
Am J Respir Crit Care Med.
2002;
166
786-787
19
Müller T, Budweiser S, Muders F, Schulz C, Jeron A, Neuhierl F, Riegger G, Pfeifer M.
Hochfrequenzoszillation beim akuten Lungenversagen des Erwachsenen.
Dtsch Arztebl.
2004;
101
A 928-934
Dr. J. Brederlau
Klinik und Poliklinik für Anästhesiologie, Zentrum Operative Medizin, Universitätsklinikum Würzburg
Oberdürrbacher Straße 6 · 97080 Würzburg
eMail: brederlau_j@klinik.uni-wuerzburg.de